Patent application number | Description | Published |
20080213268 | NEUROPILIN ANTAGONISTS - Novel anti-NRP1 antibodies and variants thereof having unique structural and functional characteristics are disclosed. Also provided are uses of the antibodies in research, diagnostic and therapeutic applications. | 09-04-2008 |
20080247951 | ANTI-ROBO4 ANTIBODIES AND USES THEREFOR - The invention provides anti-Robo4 antibodies, and compositions comprising the antibodies and methods of using these antibodies, including diagnostic and therapeutic methods. | 10-09-2008 |
20100221262 | ANTI-UNC5B ANTIBODIES AND METHODS OF USE - The invention provides anti-Unc5B antibodies, compositions and kits comprising the antibodies and methods of making and using the antibodies. The present invention also relates to use of anti-Unc5B antibodies to modulate angiogenesis and to treat or prevent disorders associated with abnormal angiogenesis. | 09-02-2010 |
20110059013 | ANTI-ROBO4 ANTIBODIES AND USES THEREFOR - The invention provides anti-Robo4 antibodies, and compositions comprising the antibodies and methods of using these antibodies, including diagnostic and therapeutic methods. | 03-10-2011 |
20110059112 | ANTI-ROBO4 ANTIBODIES AND USES THEREFOR - The invention provides anti-Robo4 antibodies, and compositions comprising the antibodies and methods of using these antibodies, including diagnostic and therapeutic methods. | 03-10-2011 |
20110256146 | NEUROPILIN ANTAGONISTS - Novel anti-NRP1 antibodies and variants thereof having unique structural and functional characteristics are disclosed. Also provided are uses of the antibodies in research, diagnostic and therapeutic applications. | 10-20-2011 |
20120064065 | Safe and functional humanized antibodies - The present invention is related to safe and functional antibodies for the therapeutic and diagnostic use in the treatment of an amyloidosis, a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease. | 03-15-2012 |
20120148599 | METHODS AND COMPOSITIONS FOR NEURAL DISEASE IMMUNOTHERAPY - The invention provides antibodies to specific neural proteins and methods of using the same. | 06-14-2012 |
20120245330 | NEUROPILIN ANTAGONISTS - Novel anti-NRP1 antibodies and variants thereof having unique structural and functional characteristics are disclosed. Also provided are uses of the antibodies in research, diagnostic and therapeutic applications. | 09-27-2012 |
20130115214 | NEUROPILIN ANTAGONISTS - Novel anti-NRP1 antibodies and variants thereof having unique structural and functional characteristics are disclosed. Also provided are uses of the antibodies in research, diagnostic and therapeutic applications. | 05-09-2013 |
20130115626 | ANTI-NEUROPILIN ANTIBODIES AND METHODS OF USE - The invention provides anti-NRP1 antibodies and methods of using the same. | 05-09-2013 |
20140255301 | METHODS FOR DETECTING NEURODEGENERATIVE DISEASES OR DISORDERS - Methods of identifying, diagnosing, and prognosing a neurodegenerative disease, or disorder, are provided. Also provided are methods for determining whether a neuron is at risk or is undergoing neurodegeneration. The methods comprise determining whether at least one of the genes tbx6 and dleu2 is overexpressed. | 09-11-2014 |
20140286963 | METHODS AND COMPOSITIONS FOR NEURAL DISEASE IMMUNOTHERAPY - The invention provides antibodies to specific neural proteins and methods of using the same. | 09-25-2014 |